2025. Adversities in adherence to endocrine therapy for breast cancer may compromise treatment and survival: an observational study. Electronic Journal Collection Health. 25, 10 (Oct. 2025), e21686. DOI:https://doi.org/10.25248/reas.e21686.2025.